Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canopy Animal Health is a specialized division of Canopy Growth Corporation dedicated to the development and commercialization of cannabinoid-based healthcare products for companion animals. The company focuses on leveraging rigorous scientific research and clinical trials, including collaborations with major academic institutions like Colorado State University, to validate the safety and efficacy of its CBD formulations. Its product portfolio includes brands such as SurityPro and Martha Stewart CBD for Pets, which target common veterinary conditions including joint pain, anxiety, and overall wellness. By applying pharmaceutical-grade standards to the pet supplement market, Canopy Animal Health aims to establish itself as a leader in evidence-based veterinary cannabinoid therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canopy Animal Health.